Biohit Oyj - Managers' Transactions, February 23, 2017 at 3:05 pm local time (EET)
____________________________________________
Person subject to the notification requirement
Name: Patrakka, Ilari
Position: Other senior manager
Issuer: Biohit Oyj
LEI: 74370089ATTSNBXJVT29
Notification type: INITIAL NOTIFICATION
Reference number: 74370089ATTSNBXJVT29_20170223120028_5
____________________________________________
Transaction date: 2017-02-20
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
ISIN: FI4000219324
Nature of the transaction: SUBSCRIPTION
(X) Linked to stock option programme
Transaction Details
(1): Volume: 1450 Unit price: 2,27660 EUR
Aggregated transactions
(1): Volume: 1450 Volume weighted average price: 2.27660 EUR
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com